IDO1 and neoplasm: In contrast to CNS metastases, we found higher IDO-positive cell numbers in the tumor mass when compared with peritumoral localization in melanoma metastases at extracranial sites, which would fit to an ongoing anti-tumoral immune response, since high levels of IFN-γ are secreted during this process.